about
Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim testsNeuropeptidomics: Mass Spectrometry-Based Identification and Quantitation of NeuropeptidesThe Role of Hypothalamic Neuropeptides in Neurogenesis and NeuritogenesisA differential role for neuropeptides in acute and chronic adaptive responses to alcohol: behavioural and genetic analysis in Caenorhabditis elegansIn vitro pharmacological characterization of RXFP3 allosterism: an example of probe dependencyVariable sensitivity to noxious heat is mediated by differential expression of the CGRP geneExistence of manserin, a secretogranin II-derived neuropeptide, in the rat inner ear: relevance to modulation of auditory and vestibular system.Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heartThe TIP39-PTH2 receptor system: unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms.Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues.TIP39 modulates effects of novelty-induced arousal on memory.SwePep, a database designed for endogenous peptides and mass spectrometry.The neuropeptide F/nitric oxide pathway is essential for shaping locomotor plasticity underlying locust phase transition.Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling.Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed.Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use DisordersDiscovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo.Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse?Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?GABAergic terminals are a source of galanin to modulate cholinergic neuron development in the neonatal forebrain.Dendritic peptide release and peptide-dependent behaviours.Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances.Identification of a role for the ventral hippocampus in neuropeptide S-elicited anxiolysis.A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones.Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral painQuantitative peptidomics to measure neuropeptide levels in animal models relevant to psychiatric disorders.Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesiclesEffects of cocaine on maternal behavior and neurochemistryDefining the Neuropeptidome of the Spiny Lobster Panulirus interruptus Brain Using a Multidimensional Mass Spectrometry-Based Platform.Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphinsIntranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.Depression-like behavior in rat: Involvement of galanin receptor subtype 1 in the ventral periaqueductal gray.G protein-coupled receptors in haematopoietic disruption.Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target.PACAP controls adrenomedullary catecholamine secretion and expression of catecholamine biosynthetic enzymes at high splanchnic nerve firing rates characteristic of stress transduction in male miceElectrophysiology of Hypothalamic Magnocellular Neurons In vitro: A Rhythmic Drive in Organotypic Cultures and Acute SlicesPACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress.Analytic framework for peptidomics applied to large-scale neuropeptide identification.Pancreatic polypeptide and its central Y4 receptors are essential for cued fear extinction and permanent suppression of fear.
P2860
Q24564195-709D92B7-2886-49F7-87A2-B0BCED032A02Q26751119-A3BA63E7-923A-4E7A-A669-B937497C15FCQ26765741-E6601B79-56AA-402F-9ACC-921BF8C31BC8Q27330029-7BE50441-4FB1-4AA1-96A6-F5B01C23CC5AQ28480533-5BEBFAAA-570E-4C1D-B504-F4CDF8771629Q28590329-5EFE0CBE-09AE-4A09-8550-0F84213B6906Q30459553-F4F3FCDB-AC3C-42D8-B471-585F114EBE78Q30475241-F44FF575-49F0-4140-A8DE-E9B8B093CB94Q30477614-F01E153A-16FE-409E-B914-64B7897A0FDEQ30485593-59E4185A-6CF7-4438-948A-B5C834F6483BQ30497579-72DD3133-E4F9-4575-9B94-06E2467338DBQ33234755-EE470A3D-1B6E-4008-84BA-D06F1306C1D4Q33591186-FBCD24F9-C5AC-4D27-B540-D2E19BB0761FQ33625911-22DDBDF7-B496-43BE-BBFE-1522879563C3Q33659932-68936DC3-360B-4593-A418-C8C8F4FB761CQ33689876-0E076234-4BF5-4383-89DB-1375390FB373Q34105209-6078AF8C-5742-4785-B376-8BDC41AB01A9Q34268757-E9A6C831-A4D6-4E95-BB45-B18726CA766DQ34268925-FE6F6783-B276-4CA7-969C-25675C643932Q34275762-4E96E9C3-5A90-4190-B2B9-DF4DFD598812Q34472079-C308E015-1D3C-4260-B953-435F4E3A44ADQ34486938-D68398B5-157A-48C5-B42B-6BB4BE471CCCQ34503551-3A8DC0D7-F2A0-4A32-8741-D311F239EB5AQ34653567-1E32A29F-DE63-47EE-AA5B-CDCA2FA2757DQ34795373-323CD19A-4436-48EA-87D6-938E3209C36DQ34954885-0391641A-E2B1-4355-9D59-31DDA637287AQ35082738-088C9DEF-1868-42EB-8D6B-88C84977EB21Q35469264-FFDBBDF4-9332-44C9-B0B7-9DE749E18594Q35778714-F9C4239C-9B44-40FA-BA6A-9059DBA63A73Q35781949-FFB352E4-42C6-4142-97F7-0D9DE25C914EQ35835788-7FECA667-655A-4220-A242-A43B5908A3F1Q35892698-526E1358-3F8D-42EB-B7AD-D7B2AD93ADB1Q36085611-D865C63C-C758-48F7-A4F2-2319054635F9Q36377200-DE91691D-658E-4EA3-82F4-DF886B6FCF45Q36469594-0A36E9CA-87C4-45C8-AFC8-4690BFCC7725Q36486100-E27FE974-270B-4089-AE26-20676033601DQ36747073-39102039-1CA2-4658-AA22-58BAD06FF793Q36838843-E60DD828-DAD4-4882-BC54-B7E540FFC352Q36871692-13063A9F-5D01-49EE-A773-75C39ABACD13Q36941269-82F3A03A-3EDE-48C9-A15E-A07B8687FBF1
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Neuropeptides: opportunities for drug discovery.
@ast
Neuropeptides: opportunities for drug discovery.
@de
Neuropeptides: opportunities for drug discovery.
@en
Neuropeptides: opportunities for drug discovery.
@fr
type
label
Neuropeptides: opportunities for drug discovery.
@ast
Neuropeptides: opportunities for drug discovery.
@de
Neuropeptides: opportunities for drug discovery.
@en
Neuropeptides: opportunities for drug discovery.
@fr
prefLabel
Neuropeptides: opportunities for drug discovery.
@ast
Neuropeptides: opportunities for drug discovery.
@de
Neuropeptides: opportunities for drug discovery.
@en
Neuropeptides: opportunities for drug discovery.
@fr
P1433
P1476
Neuropeptides: opportunities for drug discovery.
@en
P2093
Floyd Bloom
P304
P356
10.1016/S1474-4422(03)00482-4
P407
P577
2003-08-01T00:00:00Z